Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysisScientific summaryChapter 1. IntroductionChapter 2. MethodsChapter 3. ResultsChapter 4. Economic evaluationChapter 5. DiscussionAdditional informationReferencesAppendix 1. Consent procedure overviewAppendix 2. Additional tables and figuresList of abbreviationsList of supplementary material